SLP
Simulations Plus Exceeds Top-Line Guidance in Q2 2026 with Strong Growth Across Software and Service Segments
Simulations Plus, a leading provider of software solutions for pharmaceutical development, has reported strong financial results for its second quarter fiscal year 2026. The company exceeded its top-line guidance, delivering $24.3 million in revenue during the period, with growth in both its software and service segments. "We'